Alignment Healthcare, Inc. — Form 10-Q
Filed July 30, 2026 · analyzed by the Periodic Agent
10-Q
— Neutral
significance 28/100
What the filing says
Alignment Healthcare executed employment agreements with Shane Hochradel (COO, $650k salary + 85–170% bonus + $2.5M RSU + $2.5M PSU initial grants + $2.5M annual equity), Mark Kent (President MSO, same base salary and bonus, same initial equity but 1.5× severance multiplier), and Joseph S. Konowiecki (EVP Corporate Affairs, $700k salary + 85–170% bonus + $3.5M RSU + $3.5M PSU initial + $3.5M annual equity). Christopher Joyce's prior agreement was amended to report to Konowiecki instead of CEO, with continued equity vesting through March 31, 2027 if terminated without cause before that date. All agreements effective May–June 2026 with annual auto-renewal and 1–1.5× severance multiples on termination without cause.
Why this rating
Three standard C-suite hires at ~$8.5M aggregate annual equity grant value (~0.4% of $2.1B market cap). No material business change; routine executive staffing.
See more from July 30, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.